Results from this randomized trial showed that the ADR, particularly for advanced and large adenomas, was significantly higher for the G-EYE®. “The effect of the G-EYE® balloon is notable, and I expect it to become a standard tool, over time, for every colonoscopy,” said Gadi Terliuc, Chief Executive Officer of SMART Medical. “These new data add to the growing body of clinical evidence demonstrating that G-EYE® provides endoscopists with increased diagnostic yield, and we are gratified that the ACG has recognized the importance of these findings by selecting this abstract for the Outstanding Research Award in the colon cancer prevention category.”
ACG Outstanding Research Award for Colon Cancer Prevention
- October 25, 2021